Battles over Biomarker Testing Shed Light on Precision Medicine’s Inaccessibility
NonProfit Quarterly
APRIL 8, 2024
Biomarker testing is currently not available at all to Medicaid beneficiaries, and many commercial health insurance companies do not provide coverage for these tests. Additionally, insurers have pushed back on legislation that opens access to biomarker testing because of concerns about the costs of testing and tailored treatments.
Let's personalize your content